Patent ID: 9149572
Filing Date: 2015-10-06
Classification: A61K,A61M,A61P,C08B,C08J,C08K

Abstract:
1. A method of conducting peritoneal dialysis, comprising the step of: administering into the peritoneal cavity of a patient requiring dialysis, a dialysis fluid comprising: a chondroitin sulfate having a decreased molecular weight, characterized by having a weight average molecular weight of from 1000 to 20000 Da and containing a constituent disaccharide unit represented by the following structural formula in an amount of from 65% to 100% (molar ratio) of the total of the disaccharide units in the chondroitin sulfate wherein GlcA represents a D-glucuronic acid residue; GaLNAc represents an N-acetyl-D-galactosamine residue; β1-3 represents a β1-3 glycosidic linkage; β1-4 represents a β1-4 glycosidic linkage; and (6S) indicates that position 6 of the N-acetyl-D-galactosamine monosaccharide residue is sulfated.